Grantham, Mayo, Van Otterloo & Co (GMO)
CTVA icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Corteva CTVA Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio CTVA Stock Details CTVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.9M Sell
458,878
-20,453
-4% -$1.64M 0.09% 97
2026
Q1 		$40.1M Sell
479,331
-30,900
-6% -$2.33M 0.1% 88
2025
Q4 		$34.2M Buy
510,231
+118,417
+30% +$7.66M 0.09% 101
2025
Q3 		$26.5M Sell
391,814
-22,825
-6% -$1.65M 0.07% 138
2025
Q2 		$30.9M Sell
414,639
-98,358
-19% -$6.55M 0.09% 120
2025
Q1 		$32.3M Sell
512,997
-365,068
-42% -$22.6M 0.1% 133
2024
Q4 		$50M Sell
878,065
-112,600
-11% -$6.66M 0.16% 66
2024
Q3 		$58.2M Sell
990,665
-119,066
-11% -$6.5M 0.18% 62
2024
Q2 		$59.9M Buy
1,109,731
+11,704
+1% +$644K 0.2% 62
2024
Q1 		$63.3M Buy
1,098,027
+45,902
+4% +$2.37M 0.23% 61
2023
Q4 		$50.4M Buy
1,052,125
+389,020
+59% +$18.5M 0.22% 81
2023
Q3 		$33.9M Sell
663,105
-33,177
-5% -$1.76M 0.16% 117
2023
Q2 		$39.9M Buy
696,282
+94,966
+16% +$5.54M 0.18% 100
2023
Q1 		$36.3M Buy
601,316
+217,600
+57% +$13.3M 0.18% 108
2022
Q4 		$22.6M Buy
383,716
+125,100
+48% +$7.92M 0.12% 165
2022
Q3 		$14.8M Buy
258,616
+213,042
+467% +$12.4M 0.09% 207
2022
Q2 		$2.47M Sell
45,574
-2,300
-5% -$134K 0.01% 421
2022
Q1 		$2.75M Sell
47,874
-376,700
-89% -$19.3M 0.01% 412
2021
Q4 		$20.1M Sell
424,574
-175,733
-29% -$8M 0.1% 170
2021
Q3 		$25.3M Sell
600,307
-111,773
-16% -$4.84M 0.13% 144
2021
Q2 		$31.6M Buy
712,080
+110,957
+18% +$5.13M 0.16% 104
2021
Q1 		$28M Buy
601,123
+175,700
+41% +$7.77M 0.15% 95
2020
Q4 		$16.5M Sell
425,423
-130,065
-23% -$4.65M 0.1% 141
2020
Q3 		$16M Buy
555,488
+74,923
+16% +$2.11M 0.11% 109
2020
Q2 		$12.9M Buy
480,565
+443,765
+1,206% +$11.5M 0.1% 126
2020
Q1 		$865K Buy
36,800
+3,900
+12% +$107K 0.01% 524
2019
Q4 		$973K Buy
32,900
+18,900
+135% +$500K 0.01% 522
2019
Q3 		$392K Buy
+14,000
New +$405K ﹤0.01% 648

Other funds holding CTVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s CTVA Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) reduced its Corteva (CTVA) stake by 4.3% in Q2 2026, selling an estimated $1.64M and leaving 458,878 shares worth $38.9M. The position accounts for 0.09% of the portfolio, ranked #97.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CTVA in Q3 2019 and has held it in 28 quarters since. The position peaked at $63.3M in Q1 2024. 1,487 funds tracked by Wall St. Rank hold CTVA as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 458,878 shares of Corteva worth $38.9M as of Q2 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 20,453 Corteva shares in Q2 2026, an estimated $1.64M.
  • Corteva made up 0.09% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #97 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Corteva in Q3 2019 and has held it in 28 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Corteva position peaked at $63.3M in Q1 2024.
  • 1,487 funds tracked by Wall St. Rank held Corteva as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.